Briacell Therap (BCTX) Short Interest Ratio & Short Volume $2.91 -0.02 (-0.65%) Closing price 07/3/2025 03:08 PM EasternExtended Trading$2.92 +0.00 (+0.14%) As of 07/3/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Briacell Therap Short Interest DataBriacell Therap (BCTX) has a short interest of 210,300 shares, representing 3.32% of the float (the number of shares available for trading by the public). This marks a -59.36% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 574,597 shares to cover all short positions.Current Short Interest210,300 sharesPrevious Short Interest517,500 sharesChange Vs. Previous Month-59.36%Dollar Volume Sold Short$656.14 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares6,780,000 sharesFloat Size6,340,000 sharesShort Percent of Float3.32%Today's Trading Volume69,779 sharesAverage Trading Volume574,597 sharesToday's Volume Vs. Average12% Short Selling Briacell Therap? Sign up to receive the latest short interest report for Briacell Therap and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCTX Short Interest Over TimeBCTX Days to Cover Over TimeBCTX Percentage of Float Shorted Over Time Briacell Therap Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025210,300 shares $656.14 thousand -59.4%3.3%0.1 $3.12 5/31/2025517,500 shares $1.77 million +205.0%9.7%0.4 $3.42 5/15/2025169,700 shares $495.52 thousand -39.3%3.2%0.1 $2.92 4/30/2025279,400 shares $1.25 million +35.0%5.2%0.2 $4.46 4/15/2025206,900 shares $775.88 thousand +7.8%6.0%0.1 $3.75 3/31/2025191,900 shares $700.44 thousand +2.0%5.5%0.6 $3.65 3/15/2025188,100 shares $722.30 thousand +2.2%5.4%0.6 $3.84 2/28/2025184,100 shares $675.65 thousand -9.0%5.4%0.5 $3.67 2/15/2025202,300 shares $880.01 thousand +113.4%5.9%0.5 $4.35 1/31/202594,800 shares $475.90 thousand -94.2%2.8%0.3 $5.02 Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Briacell Therap and its competitors with MarketBeat's FREE daily newsletter. 1/15/20251,620,000 shares $9.72 million -1.8%4.0%1.2 $6.00 12/31/20241,650,000 shares $932.25 thousand -30.7%4.2%1.1 $0.57 12/15/20242,380,000 shares $1.57 million +245.7%6.0%1 $0.66 11/30/2024688,400 shares $676.28 thousand +28.7%2.1%0.1 $0.98 11/15/2024534,800 shares $318.21 thousand -28.2%1.7%0.1 $0.60 10/31/2024745,100 shares $605.92 thousand +2.4%2.3%0.2 $0.81 10/15/2024727,600 shares $654.62 thousand +62.0%2.3%0.2 $0.90 9/30/2024449,200 shares $557.01 thousand -72.8%1.6%0.1 $1.24 9/15/20241,650,000 shares $924.83 thousand +549.1%6.7%0.5 $0.56 8/31/2024254,200 shares $200.21 thousand -39.1%1.7%0.1 $0.79 8/15/2024417,200 shares $236.97 thousand -10.2%2.7%1.1 $0.57 7/31/2024464,400 shares $349.46 thousand -18.4%3.0%1.2 $0.75 7/15/2024569,400 shares $529.54 thousand +1.1%3.7%1.6 $0.93 6/30/2024563,300 shares $642.16 thousand -10.4%3.6%4.7 $1.14 6/15/2024628,300 shares $892.19 thousand -12.6%4.1%5.2 $1.42 5/31/2024718,900 shares $1.21 million +11.3%4.8%5.9 $1.69 5/15/2024645,700 shares $1.08 million -3.3%4.3%5.6 $1.68 4/30/2024667,700 shares $1.45 million -2.5%4.8%8.9 $2.17 4/15/2024685,000 shares $1.59 million +1.1%4.9%8.1 $2.32 3/31/2024677,900 shares $1.94 million -7.6%4.8%7.2 $2.86 3/15/2024733,300 shares $2.16 million -7.9%5.2%6.8 $2.95 2/29/2024795,900 shares $2.75 million -2.8%5.7%7.7 $3.46 2/15/2024818,800 shares $2.64 million -6.1%5.8%8.3 $3.23 1/31/2024871,900 shares $3.59 million +1.0%6.2%9.2 $4.12 1/15/2024863,700 shares $3.79 million +0.6%6.2%7.6 $4.39 12/31/2023858,500 shares $5.02 million +1.6%6.1%8 $5.85 12/15/2023845,200 shares $3.49 million -11.2%6.0%8.8 $4.13 11/30/2023951,900 shares $5.04 million -2.8%6.8%10.5 $5.29 11/15/2023979,100 shares $4.31 million +3.8%7.0%10 $4.40 10/31/2023943,400 shares $4.01 million -7.5%7.1%9.2 $4.25The day and month stocks are most likely to crash next (Ad)Good News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history gives him 90% historical confidence that stocks will end 2025 up. However, he also has bad news: the same data also tells him the REAL market crash will likely arrive in 2026.Click here to see the month and day he estimates it will begin 10/15/20231,020,000 shares $5.00 million -2.9%7.7%12 $4.90 9/30/20231,050,000 shares $6.56 million -3.7%8.0%12.5 $6.25 9/15/20231,090,000 shares $6.63 million -3.5%8.3%11.8 $6.08 8/31/20231,130,000 shares $8.12 million +3.7%8.6%11.9 $7.19 8/15/20231,090,000 shares $7.54 million +3.8%8.3%11.8 $6.92 7/31/20231,050,000 shares $7.02 million +1.0%8.0%10 $6.69 7/15/20231,040,000 shares $6.71 million -1.0%9.1%9.4 $6.45 6/30/20231,050,000 shares $6.74 million -4.6%9.2%8.4 $6.42 6/15/20231,100,000 shares $6.67 million -12.7%9.7%8.8 $6.06 5/31/20231,260,000 shares $7.47 million -6.0%11.4%9.9 $5.93 5/15/20231,340,000 shares $8.80 million -3.6%12.2%9.6 $6.57 4/30/20231,390,000 shares $10.34 million -4.1%12.6%9.1 $7.44 4/15/20231,450,000 shares $10.44 million +1.4%13.2%8.6 $7.20 3/31/20231,430,000 shares $10.65 million -4.7%13.9%7.6 $7.45 3/15/20231,500,000 shares $10.50 million -6.3%14.6%7.1 $7.00 2/28/20231,600,000 shares $11.33 million +4.6%15.5%7.2 $7.08 2/15/20231,530,000 shares $12.22 million +1.3%14.9%6.7 $7.99 1/31/20231,510,000 shares $11.29 million +15.3%14.7%6.7 $7.48 1/15/20231,310,000 shares $8.71 million -0.8%12.6%5.1 $6.65 12/30/20221,320,000 shares $5.77 million -5.7%12.7%5.6 $4.37 12/15/20221,400,000 shares $7.87 million No Change13.5%5.6 $5.62 11/30/20221,400,000 shares $7.52 million No Change13.5%4.1 $5.37 11/15/20221,400,000 shares $7.69 million +12.9%13.5%3.8 $5.49 10/31/20221,240,000 shares $6.82 million -10.1%11.9%3.2 $5.50 10/15/20221,380,000 shares $9.12 million +3.8%13.3%3.4 $6.61 9/30/20221,330,000 shares $7.47 million -16.9%12.8%3.4 $5.62 9/15/20221,600,000 shares $12.91 million +2.6%15.4%3.9 $8.07 8/31/20221,560,000 shares $12.12 million +4.0%15.0%4.2 $7.77 8/15/20221,500,000 shares $10.34 million -4.5%14.4%4.3 $6.89 7/31/20221,570,000 shares $10.21 million -10.8%15.7%4.2 $6.50 7/15/20221,760,000 shares $10.70 million +8.0%15.1%4.6 $6.08 6/30/20221,630,000 shares $9.41 million -0.6%14.0%2 $5.77 6/15/20221,640,000 shares $10.61 million -3.0%14.1%1.9 $6.47 5/31/20221,690,000 shares $8.47 million -0.6%14.8%2.1 $5.01 5/15/20221,700,000 shares $8.40 million -9.1%14.9%2 $4.94 4/30/20221,870,000 shares $13.02 million -24.3%15.7%2.2 $6.96 4/15/20222,470,000 shares $21.27 million +27.3%19.4%2.6 $8.61 3/31/20221,940,000 shares $19.67 million No Change15.1%3.2 $10.14 3/15/20221,940,000 shares $15.62 million +6.0%15.1%3.3 $8.05 2/28/20221,830,000 shares $13.96 million No Change13.7%2.1 $7.63 2/15/20221,830,000 shares $14.02 million +10.2%13.7%1.5 $7.66 1/31/20221,660,000 shares $10.49 million -5.7%13.2%1.2 $6.32 1/15/20221,760,000 shares $14.87 million +17.3%14.0%1.2 $8.45 12/31/20211,500,000 shares $12.42 million -13.3%12.0%1 $8.28 12/15/20211,730,000 shares $13.82 million -8.0%13.9%0.9 $7.99 11/30/20211,880,000 shares $18.50 million +8.1%15.8%0.9 $9.84 11/15/20211,740,000 shares $16.58 million +5.5%14.4%0.9 $9.53 10/29/20211,650,000 shares $13.12 million -15.0%13.7%0.8 $7.95 10/15/20211,940,000 shares $15.89 million -16.7%16.2%0.9 $8.19 9/30/20212,330,000 shares $18.87 million +22.6%19.5%1 $8.10The day and month stocks are most likely to crash next (Ad)Good News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history gives him 90% historical confidence that stocks will end 2025 up. However, he also has bad news: the same data also tells him the REAL market crash will likely arrive in 2026.Click here to see the month and day he estimates it will begin 9/15/20211,900,000 shares $13.62 million +10.5%15.9%0.9 $7.17 8/31/20211,720,000 shares $11.68 million +4.9%14.6%0.7 $6.79 8/13/20211,640,000 shares $9.84 million No Change14.0%0.4 $6.00 BCTX Short Interest - Frequently Asked Questions What is Briacell Therap's current short interest? Short interest is the volume of Briacell Therap shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 210,300 shares of BCTX short. 3.32% of Briacell Therap's shares are currently sold short. Learn More on Briacell Therap's current short interest. What is a good short interest percentage for Briacell Therap? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.32% of Briacell Therap's floating shares are currently sold short. Is Briacell Therap's short interest increasing or decreasing? Briacell Therap saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 210,300 shares, a drop of 59.4% from the previous total of 517,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Briacell Therap's float size? Briacell Therap currently has issued a total of 6,780,000 shares. Some of Briacell Therap's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Briacell Therap currently has a public float of 6,340,000 shares. How does Briacell Therap's short interest compare to its competitors? 3.32% of Briacell Therap's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Briacell Therap: MacroGenics, Inc. (9.54%), Cellectis S.A. (0.46%), TScan Therapeutics, Inc. (5.18%), OKYO Pharma Limited Sponsored ADR (0.78%), Unicycive Therapeutics, Inc. (3.49%), Pliant Therapeutics, Inc. (5.95%), Jasper Therapeutics, Inc. (12.23%), Zura Bio Limited (6.91%), ESSA Pharma Inc. (1.92%), XBiotech Inc. (5.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Briacell Therap stock? Short selling BCTX is an investing strategy that aims to generate trading profit from Briacell Therap as its price is falling. BCTX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Briacell Therap? A short squeeze for Briacell Therap occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTX, which in turn drives the price of the stock up even further. How often is Briacell Therap's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies MacroGenics Short Interest Cellectis Short Interest TScan Therapeutics Short Interest OKYO Pharma Short Interest Unicycive Therapeutics Short Interest Pliant Therapeutics Short Interest Jasper Therapeutics Short Interest Zura Bio Short Interest ESSA Pharma Short Interest XBiotech Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCTX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Briacell Therap Please log in to your account or sign up in order to add this asset to your watchlist. Share Briacell Therap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCTX Stock Alerts